Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-ncov/index.html

Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

Filetype[PDF-108.58 KB]


  • English
    • Details Supporting Files You May Also Like

    Details:

    • Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    • Description:
      Updated Sept. 19, 2020

      Summary of Recent Changes

      Revisions made on September 19, 2020 include:

      • New link under Resources to DLS Preparing and Supporting Laboratories Responding to COVID-19 page

      Revisions made on August 7, 2020 include:

      • Standard Precautions

      Revisions made on July 16, 2020 include:

      • Added DOT resources to Specimen Packing and Shipping and Resource section

      Revisions made on July 13, 2020 to update:

      • Language for virus isolation

      Revisions made on June 3, 2020 include:

      • Added anatomic pathology guidance for COVID-19

      • Updated Point-of-Care testing guidance for COVID-19

      Revisions made on May 11, 2020 include recommendations for:

      • Point-of-Care testing guidance for COVID-19

      Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2. Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection. Such specimens should be labeled accordingly, and the laboratory should be alerted to ensure proper specimen handling. General and specific biosafety guidelines for handling SARS-CoV-2 specimens are provided below. For additional information on handling SARS-CoV-2 specimens, refer to the Laboratory Biosafety Frequently Asked Questions.

    • Content Notes:
      General Guidance -- Routine Viral Testing -- Anatomic Pathology -- Decentralized and Point of Care Testing -- Procedures with a High Likelihood to Generate Droplets or Aerosols -- Environmental Specimen Testing -- Virus Isolation -- Decontamination -- Laboratory Waste Management -- Specimen Packing and Shipping -- Resources.
    • Subject:
    • Series:
      Coronavirus Disease 2019 (CoVID-19)
    • Document Type:
      Webpage
    • Genre:
      Guideline
    • Collection(s):
      Stephen B. Thacker CDC Library collection
    • Main Document Checksum:
    • File Type:

    Supporting Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov